NCT00568763View on ClinicalTrials.gov

Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 25, 2005

Primary Completion Date

May 10, 2010

Study Completion Date

May 24, 2018

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

sargramostim

OTHER

immunoenzyme technique

OTHER

immunohistochemistry staining method

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

PROCEDURE

biopsy

PROCEDURE

cryosurgery

PROCEDURE

radiofrequency ablation

Trial Locations (1)

55905

Mayo Clinic Cancer Center, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00568763 - Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter